Tag: Ranbaxy
Sun Pharma Must Face Ranbaxy Antitrust Class Actions
Sun Pharmaceutical has lost a bid to avoid facing a trial over allegations that an Indian drugmaker it acquired engaged in an anticompetitive scheme to...
Judge OKs Multiple Classes In Ranbaxy Generic Delay Case
A federal judge has approved multiple classes in litigation accusing Indian generic drugmaker Ranbaxy Laboratories of delaying the launch of generic drugs by submitting...
US: Ranbaxy pay-for-delay trial starts
As complex as reverse-payment antitrust lawsuits can be, the one being litigated against generic drug maker Ranbaxy over its settlement with Cephalon can be...
The Rising Tide: Competition Law Enforcement in the Indian Pharmaceutical Sector
This article is part of a Chronicle. See more from this Chronicle
Kalyani Singh, Nov 24, 2014
Given the sensitivity and direct impact on consumers, it...
